Further empirical research is required to fill in the current gaps in the literature with respect to the causal effect of chemerin on lung cancer development and progression, as well as its effects on biological indicators of cancer such as proliferation, metastasis, and invasion. This evidence concerns the gene RARRES2 and lung cancer.